Only the tip of the Iceberg? Role of ATP7B‐exon skipping in Wilson disease.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1375, doi. 10.1111/liv.13924
- By:
- Publication type:
- Article
Works matching IS 14783223 AND DT 2018 AND VI 38 AND IP 8
Results: 20
1
2
An uncommon presentation of alcoholic liver disease.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
3
Role and mechanisms of autophagy in acetaminophen‐induced liver injury.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1363, doi. 10.1111/liv.13866
- By:
- Publication type:
- Article
4
Specific issues concerning the management of patients on the waiting list and after liver transplantation.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1338, doi. 10.1111/liv.13755
- By:
- Publication type:
- Article
5
Presumed missense and synonymous mutations in ATP7B gene cause exon skipping in Wilson disease.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1504, doi. 10.1111/liv.13754
- By:
- Publication type:
- Article
6
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1442, doi. 10.1111/liv.13732
- By:
- Publication type:
- Article
7
Acute kidney injury, but not sepsis, is associated with higher procedure‐related bleeding in patients with decompensated cirrhosis.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1437, doi. 10.1111/liv.13712
- By:
- Publication type:
- Article
8
FACT‐Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1468, doi. 10.1111/liv.13711
- By:
- Publication type:
- Article
9
A simple clinical model predicts incident hepatic steatosis in a community‐based cohort: The Framingham Heart Study.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1495, doi. 10.1111/liv.13709
- By:
- Publication type:
- Article
10
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1459, doi. 10.1111/liv.13707
- By:
- Publication type:
- Article
11
Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1427, doi. 10.1111/liv.13704
- By:
- Publication type:
- Article
12
Association between cotinine‐verified smoking status and risk of nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1487, doi. 10.1111/liv.13701
- By:
- Publication type:
- Article
13
High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1449, doi. 10.1111/liv.13697
- By:
- Publication type:
- Article
14
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1475, doi. 10.1111/liv.13696
- By:
- Publication type:
- Article
15
Reliability and safety of transnasal compared to conventional endoscopy for detecting oesophageal varices in cirrhotic patients.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1418, doi. 10.1111/liv.13692
- By:
- Publication type:
- Article
16
Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health‐related quality of life for patients with hepatitis C.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1377, doi. 10.1111/liv.13690
- By:
- Publication type:
- Article
17
Inpatient hospital burden of hepatitis C‐diagnosed patients with decompensated cirrhosis.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1402, doi. 10.1111/liv.13681
- By:
- Publication type:
- Article
18
High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1–infected patients with severe chronic kidney disease.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1395, doi. 10.1111/liv.13674
- By:
- Publication type:
- Article
19
Issue Information.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1333, doi. 10.1111/liv.13576
- Publication type:
- Article
20
HCV treatment initiation in persons with chronic kidney disease in the directly acting antiviral agents era: Results from ERCHIVES.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1411, doi. 10.1111/liv.13672
- By:
- Publication type:
- Article